Cholesterol emboli syndrome laboratory findings

Cholesterol emboli syndrome Microchapters
Home
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Cholesterol emboli syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholesterol emboli syndrome laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholesterol emboli syndrome laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholesterol emboli syndrome laboratory findings
CDC on Cholesterol emboli syndrome laboratory findings
Cholesterol emboli syndrome laboratory findings in the news
Blogs on Cholesterol emboli syndrome laboratory findings
Directions to Hospitals Treating Cholesterol emboli syndrome
Risk calculators and risk factors for Cholesterol emboli syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

• Laboratory findings consistent with the diagnosis of Cholesterol emboli syndrome include
  • Tests for inflammation (C-reactive protein and the erythrocyte sedimentation rate) are typically elevated
  • abnormal liver enzymes
  • If the kidneys are involved, tests of renal function (such as urea and creatinine) are elevated.
  • The complete blood count may show particularly high numbers of a type of white blood cell known as eosinophils (more than 0.5 billion per liter); this occurs in only 60-80% of cases, so normal eosinophil counts do not rule out the diagnosis.
  • Examination of the urine may show red blood cells (occasionally in casts as seen under the microscope) and increased levels of protein; in a third of the cases with kidney involvement, eosinophils can also be detected in the urine.
  • If vasculitis is suspected, complement levels may be determined as reduced levels are often encountered in vasculitis; complement is a group of proteins that forms part of the innate immune system. Complement levels are frequently reduced in cholesterol embolism syndrome, limiting the use of this test in the distinction between vasculitis and cholesterol embolism syndrome.

• If Organ damage occurs, laboratory findings include

  • Renal failure - increased serum creatinine and BUN greenberg
  • Myocardial infarction - serum creatine kinase (CPK) and troponin elevation
  • Mesenteric ischemia - Bloody (OB+) stool common

Biomarker Studies

• increased ESR and CRP
• Peripheral eosinophilia moolenaarneth
• eosinophiluria - usually in patients with cholesterol-renal disease
• Hematuria
• proteinuria
• May have leukocytosis (even >20K/µL) with left shift
• Hypocomplementemia is common
• Thrombocytopenia due to aggregation and complement activation

References

Template:WikiDoc Sources